Armenian banks bought some $110.8 million at local forex market from 14th to 18th of December

YEREVAN, December 21. / ARKA /. Armenian commercial banks bought some $110.8 million at the local forex market from 14th to 18th of December at the weighted average exchange rate of 482.39 drams per $1, the Central Bank said.

It said they also bought 10.2 million euros at the weighted average exchange rate of 524.01 drams per €1 and about 1.2 billion Russian rubles at the weighted average exchange rate of 6.81 drams per 1 ruble.

At the same time, they sold about $123.3 million, €10. 8 million and 593.7 million Russian rubles at the weighted average exchange rates of 484.2 drams, 531.12 drams and 6.92 drams respectively.
Besides, from the 7th to 13th of December the banks provided 51.6 billion drams worth loans in the national currency and $54.4 million worth loans in USD. ($ 1 – 481.04 drams). -0-

spot_img

POPULAR

Armbanks Weekly Digest: Key Events in the Armenian Financial Market (August 17–23)

Key developments in Armenia's financial market this week included new banking compliance requirements, measures against account fraud, and decisions related to capital market development.

Armenia set to enhance development of its capital market, targeting large issuers and new investors

YEREVAN, August 20. /ARKA/. The Armenian government prioritizes diversifying funding sources and advancing the capital market to foster sustainable and productive economic growth.

Armenian dram weakened against the dollar and strengthened against the euro and ruble: Central Bank

The average market exchange rate for the US dollar to the Armenian dram, formed on the Armenian foreign exchange market as of August 24, 2026, increased by 0.22 points to 365.38 drams compared to August 21.

US dollar, euro, and ruble drop against Armenian dram

YEREVAN, August 18. /ARKA/. The average market exchange rate for the US dollar against the Armenian dram on the Armenian foreign exchange market as of August 18, 2026, fell by 0.25 points to 365.25 drams compared to August 17.

Shares of Noubar Afeyan’s Moderna soared 124% on news of a successful cancer vaccine trial

YEREVAN, August 20. /ARKA/. Shares of the biotech company Moderna soared 123.6% at the start of trading in the US on August 19, reaching a peak of $140.77, according to trading data. Shares of the pharmaceutical company Merck also rose 11.6% to $150.85, according to Forbes.ru.

LATEST NEWS

spot_imgspot_imgspot_img